Health ❯ Nutrition ❯ Weight Management

Pharmaceuticals

Clinical Trials GLP-1 Receptor Agonists GLP-1 Drugs GLP-1 Medications Ozempic GLP-1 Weight Loss Treatments Side Effects of Medications GLP-1 Mechanism Semaglutide

Lilly Still Dominates GLP‑1 Market as New Rivals Gain Traction

Rising trial wins for small firms plus new oral pills are testing Lilly's revenue‑heavy lead.

Kendra Wilkinson Credits Effecty After Dropping Several Dress Sizes on GLP-1 Regimen

Semaglutide Causes Weight Loss by Raising cAMP in Hindbrain Neurons, NIH Study Finds

Genetic Clues Help Explain GLP‑1 Differences in Results

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

Novo Nordisk Extends Weight‑Loss Lead as Amgen’s Once‑Monthly MariTide Reaches Phase 3

Eli Lilly Tightens GLP-1 Grip, Guides Up to $83 Billion for 2026

UK Regulator Flags Rare Pancreatitis, Including Deaths, Tied to Wegovy and Mounjaro

Medicare GLP-1 Use Surges as CMS Advances Coverage Expansion and Lilly Eyes Q2 Pill Launch

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

GLP-1 Drugs Tied to Slower Alcohol Absorption and Weaker Intoxication in Virginia Tech Pilot

Ektaa Kapoor Says Ozempic Video Was About Body-Shaming Promo, Not Ram Kapoor

Serena Williams Says GLP-1 Treatment Helped Her Lose More Than 14 Kilograms

Ricki Lake Reveals Lower Face and Neck Lift After 40-Pound Weight Loss

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

U.S. Obesity Rates Decline as Weight-Loss Drugs Gain Popularity